Referencias: 1. Ashoush S. El-kady O, Al-Hawwary G, Othman A. (2017). The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial. Acta Obstet Gynecol Scand. 96: 1460-1466 2. Coomarasamy A, Devall A, Brosens J, et al. (2020). Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obst Gynecol. 167-176 3. Di Renzo G, Giardina I, Clerici G, et al. (2016). Progesterone in normal and pathological pregnancy. Horm Mol Biol Clin Invest. 2016; 27(1): 35-48 4. Nagy B, Szekeres J, Kovacs G, et al. (2021). Key to life: physiological role and clinical implications of progesterone. Int J Mol Sci. 22: 11039 5. Wahabi H, Fayed A, Esmaeil S, Bahkalt K. (2018). Progestogen for treating threatened miscarriage.Cochrane Database of Systematic Reviews. Issue 8. Art No.: CD005943 6. Enatsu Y, Enatsu N, Kishi K, et al. Effectiveness of high-dose transvaginal progesterone supplementation for women who are undergoing a frozen-thawed embryo transfer. Reprod Med Biol. 2018; 17(3): 242-248 7. Ciampaglia W, Cognigni G. (2015). Clinical use of progesterone in infertility and assisted reproduction. Acta Obstet Gynecol Scand. 94: 17-27 8. Fitzpatrick L, Good A. (1999). Micronized progesterone: clinical indications and comparison with current treatments. Fertil Steril. 72; 389-97 9. De Lignieres B. (1999). Oral micronized progesterone. Clin Ther. 21(1): 41-60 10. Elmaogullari S, Aycan Z. (2018) Abnormal uterine bleeding in adolescents. J Clin Res Pediatr Endocrinol. 10(3): 191-197 11. Sitruk R, Bricaire C, de Lignieres B, et al. (1987). Oral micronized progesterone. Contraception. 36(4): 373-402